The featured products include compounded products which are not FDA-approved. The FDA does not evaluate compounded drugs for safety, effectiveness, or quality.

Compounded products offered by InstaRX has not been evaluated or approved by the FDA for safety, effectiveness, or quality. It is not the same as, and is not a substitute for, FDA-approved products. Do not assume comparable safety, quality, or efficacy.

Medication eligibility and prescriptions are determined solely by licensed medical providers based on clinical appropriateness. Not all individuals will qualify for medication-based treatment. Always consult a licensed healthcare professional before beginning any weight loss or wellness program.

GLP-1 receptor agonists (e.g., semaglutide, tirzepatide) may cause serious side effects, including gastrointestinal symptoms and, in rare cases, thyroid C-cell tumors. Do not use GLP-1 medications if you or your family have a history of medullary thyroid carcinoma (MTC) or Multiple Endocrine Neoplasia syndrome type 2 (MEN 2). Patients should be monitored for symptoms such as persistent nausea, vomiting, abdominal pain, or changes in thyroid function.

Weight loss outcomes vary based on individual factors including starting weight, metabolic health, lifestyle, and adherence to the prescribed program. Testimonials and reviews reflect individual experiences and are not guarantees of specific outcomes.

InstaRX is a technology platform that facilitates access to independent third-party healthcare providers and pharmacies. InstaRX itself does not provide medical care, make treatment decisions, or dispense medications. All clinical decisions are made by licensed providers in accordance with applicable laws and standards of care.